{"id":"W2135856975","doi":"10.1186/1750-1326-4-51","title":"Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo","year":2009,"lang":"en","type":"article","venue":"Molecular Neurodegeneration","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University of Alberta","funders":"Alzheimer's Society; Wellcome Trust; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Alzheimer's Association; Cure Alzheimer's Fund; National Institute on Aging","keywords":"Extracellular; In vivo; Genetically modified mouse; Pharmacology; Amyloid precursor protein; In vitro; Amyloid (mycology); Chemistry; Transgene; Medicine; Alzheimer's disease; Internal medicine; Biology; Pathology; Biochemistry; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001221456,0.0005800179,0.0003698325,0.0001814363,0.0001624995,0.0002710569,0.0003225124,0.0003603572,0.001210995],"category_scores_gemma":[0.0001120879,0.0001499159,0.0002548008,0.0001616019,0.0002336519,0.0002074289,0.0001167797,0.0006494264,0.0003370471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002344079,"about_ca_system_score_gemma":0.0002062804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007214308,"about_ca_topic_score_gemma":0.001901411,"domain_scores_codex":[0.9998906,0.00001798379,0.00001277055,0.00002150382,0.00002595739,0.0000312528],"domain_scores_gemma":[0.9998817,0.00002209904,0.00004263639,0.00001402058,0.00001224392,0.00002721382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007487835,0.0001446299,0.0001444216,0.00007307981,0.00001321851,0.00006710173,0.00001628143,0.00004605233,0.9973532,0.0000156588,0.00004184671,0.001335683],"study_design_scores_gemma":[0.00005162315,0.004909586,0.002600103,0.000008976363,0.00003978524,0.0002177287,0.00002514312,0.0001712633,0.9910423,0.0000113564,0.0009165872,0.000005505571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950489,0.002644194,0.0006009038,0.00005410873,0.00003704351,0.00004272466,0.000289712,0.00008090075,0.001201519],"genre_scores_gemma":[0.9923561,0.003073174,0.001948885,0.00004434333,0.0000302611,0.00006258315,0.0007297967,0.00001106455,0.001743877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001210995,"threshold_uncertainty_score":0.004051149,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02847158214787858,"score_gpt":0.3027386716626232,"score_spread":0.2742670895147446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}